Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

March 20, 2018

Endospan's Horizon EVAR System Receives CE Mark Approval

March 21, 2018—Endospan announced that it has received European CE Mark approval for its Horizon stent graft system for endovascular aneurysm repair of abdominal aortic aneurysms. The Israel-based company plans to work with potential partners to commercialize the Horizon system.

According to Endospan, the Horizon platform can be used in a 14-F single-sided approach. The device is supported by pivotal trial data with > 3 years of follow-up.

Additionally, the company noted that it has initiated the European regulatory process to market its Nexus stent graft system for the treatment of aortic arch disease. The Nexus system is currently only approved for investigational use in Europe.

Advertisement

March 21, 2018

Pilot Study Evaluates Use of Virtual Reality in Planning Endovascular Repair of Splenic Artery Aneurysms

left-arrow Created with Sketch. Previous Article

March 21, 2018

Pilot Study Evaluates Use of Virtual Reality in Planning Endovascular Repair of Splenic Artery Aneurysms

Next Article right-arrow Created with Sketch.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button
)